About this webinar

Recorded On: Wednesday, July 10, 2019

Before accessing the clinical evidence associated with a specific variation, one must establish that the variant is likely to be a driver mutation, which generates functional changes that enhance tumor cell proliferation. In this webcast, we will discuss VSClinical’s capabilities for determining the oncogenicity of a variant. This will include a deep dive into our oncogenicity scoring system and a discussion of the various criteria used to distinguish driver mutations from benign variations and variants of uncertain significance.

What you will learn in this webcast:

• How to evaluate the oncogenicity of a variant in VSClinical
• What evidence to consider when classifying LoF variants
• How to examine the in-silico evidence for missense variants
• How to evaluate a variant's rate of occurrence in somatic catalogs